Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

Background: The co-receptor lymphocyte-activation gene-3 (LAG3, LAG-3, CD223) is a potential target for immune checkpoint inhibition immunotherapies. However, little is known about the biological and clinical significance of LAG3 DNA methylation in melanoma and its microenvironment. Methods: We eval...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anne Fröhlich, Judith Sirokay, Simon Fietz, Timo J. Vogt, Jörn Dietrich, Romina Zarbl, Mike Florin, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Lukas Flatz, Sandra S. Ring, Carsten Golletz, Torsten Pietsch, Sebastian Strieth, Peter Brossart, Gerrit H. Gielen, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg, Dimo Dietrich
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2020-09-01
Schriftenreihe:	EBioMedicine
Schlagworte:	LAG3 DNA Methylation Melanoma Predictive Biomarker Immunotherapy
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2352396420303388
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!